Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine

19 December 2018
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine

HIGH POINT, N.C., June 29, 2018 – Dr. Scott Hemby, chair of basic pharmaceutical sciences in the Fred Wilson School of Pharmacy at High Point University, led and published a new study about kratom, a plant that the scientific community and general public have debated regarding its potential to treat pain without being addictive.

 

You can view the full journal published in addiction biology here.

 

 



To overview

This website uses cookies to ensure you get the best experience on our website. Read more about our Cookie Policy.